Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Delta 9 Cannabis Inc DLTNF

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.


GREY:DLTNF - Post by User

Comment by Binkyman69on Nov 02, 2021 10:38pm
148 Views
Post# 34080419

RE:RE:RE:RE:News - DN Renews Right to Rebuy Shares and DBs

RE:RE:RE:RE:News - DN Renews Right to Rebuy Shares and DBs
knights101 wrote: What does this mean----The Company sought approval of the NCIB because it believes that, from time to time, the market price of the Common Shares and Debentures may not fully reflect the value of the Common Shares and Debentures. The Company believes that, in such circumstances, the purchase of Common Shares and Debentures represents an accretive use of capital.


Dont worry you dont need to know what it means.. they wont be using it anyways.. was put out last year in an attempt to make it appear as if they were actively doing something to get SP up.. was just for optics though they didnt use it.. 0 $ of shares /debentures were re purchased.. Will be the same for this year 2.. margins are falling drastically. Industry avg price per gram sold is too low and government taxation is too high. Any weed company that doesn't have cash 2 survive until supply glut is resolved is in trouble. OGI somehow able 2 get 250 million deal from BAT but DN ( easily a better company) is going to default on 11m debentures mid 2022.. management should give their head a shake for the mess that this has become.
<< Previous
Bullboard Posts
Next >>